trending Market Intelligence /marketintelligence/en/news-insights/trending/QGt_LsY9yJqDCRCjcQOegw2 content esgSubNav
In This List

Acer Therapeutics appoints chief medical officer

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


Acer Therapeutics appoints chief medical officer

Acer Therapeutics Inc., which has merged with Opexa Therapeutics Inc., appointed William Andrews as chief medical officer to replace Robert Steiner.

Previously, Andrews held senior leadership positions and positions of increasing responsibility at Aegerion Pharmaceuticals Inc., Santhera Pharmaceuticals Holding AG, Sepracor, and ClinQuest.